August delivered a compact but meaningful set of oncology updates: two U.S. FDA accelerated approvals and several practice-informing papers across skin, lung, head & neck, kidney, colorectal, breast, and hematologic cancers. Lung cancer 1) HER2-mutant NSCLC — zongertinib wins FDA accelerated approval 2) KRAS G12C NSCLC — adagrasib bests docetaxel in phase 3 (KRYSTAL-12) Brain […]
Cancer breakthroughs & approvals in August 2025 Read More »
A cancer diagnosis can feel overwhelming, stripping away a sense of control. Yet experts urge patients and caregivers to focus on what you can control. In other words, find the “CAN” in your cancer journey – the things you can do, even when many factors remain beyond your control. This article explores practical areas where you do have power
Finding the “CAN” in Cancer: Empowerment and Action Read More »
Modern chemotherapy is much kinder than its reputation. Thanks to advances in medicine and supportive care, many side effects have improved significantly, allowing patients to maintain a near-normal life during treatment. This article explores how chemo side effects have become far more manageable, backed by data and patient experiences, and offers tips for living well through therapy.
Kinder Chemotherapy Side Effects: Two Decades of Gradual Improvement Read More »
Following are key take‑home messages from ESMO GI 2025 (Barcelona, 2–5 July), organized by cancer type.
Highlights From ESMO Gastrointestinal Cancers Congress 2025 Read More »
Here is a summary of major cancer-related news in June 2025. The cancer treatment landscape has changed rapidly every month, and Patient Savvy will keep you updated
Cancer News: Updated in June 2025 Read More »
Early Access Programs (EAPs) provide a valuable solution, helping patients access new treatments even before official approval in their home countries. This article discusses these programs globally and outlines proactive steps patients and caregivers can take.
Early Access Program For Non-Approved Medicines Outside the US Read More »
Both paths underscore the same truth: cancer is complex. While it’s natural to rely heavily on doctors for answers, there’s significant power in becoming an informed participant in your own care. With the right approach, you can confidently understand and influence your treatment decisions quickly, potentially saving months of stress and uncertainty. Here’s a simple yet powerful 3-step approach to help you confidently navigate your cancer journey
How to Confidently Understand Your Cancer Treatment in Just One Day Read More »
Scanxiety isn’t just about CTs, MRIs, or PET scans. It’s also about waiting for biomarker blood tests, ctDNA monitoring, or tumor markers. It’s the unease that creeps in days before the appointment, the tension of watching the doctor’s face as they read your chart, the overwhelming silence that follows when results are pending.
Scanxiety: A Silent Struggle Shared by Many Patients and Caregivers Read More »
The American Society of Clinical Oncology (ASCO) 2025 annual meeting, held from May 30 to June 3, 2025, featured significant clinical developments across multiple cancer treatment modalities, with particular attention to antibody-drug conjugates (ADCs), CAR-T cell therapies, and immuno-oncology agents.
ASCO 2025 Highlights: Key Clinical Developments and Regulatory Updates Read More »
This comprehensive guide will walk you through the essential steps to take immediately following your diagnosis, helping you move from initial shock to informed action while maintaining hope and agency throughout your cancer journey.
What to Expect After a Cancer Diagnosis Read More »
